And it also shows its therapeutic effect on gastroesophageal reflux disease rats by reducing the levels of pro-inflammatory biomarkers such as IL-1β, IL-6 and TNF-α (Hesari et al., 2018). Here, IL1B is linked to gastroesophageal reflux disease.